Cardiff Oncology, Inc. short interest in 2022
In 2022, Cardiff Oncology, Inc.'s disclosed short interest ran from 9.31% of shares outstanding on 14 Jan 2022 to 2.44% on 30 Dec 2022, a change of -6.87 percentage points. The year's high was 9.31% on 14 Jan 2022 and its low 2.44% on 30 Dec 2022, averaging 5.44% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.03 days on 31 May 2022. Full history: Cardiff Oncology, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 9.31% (14 Jan 2022)
- End of year
- 2.44% (30 Dec 2022)
- Change
- -6.87 pp
- High
- 9.31% (14 Jan 2022)
- Low
- 2.44% (30 Dec 2022)
- Average
- 5.44%
- Highest days to cover
- 8.03 (31 May 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 9.31% | 6.26 | |
| 31 Jan 2022 | 7.84% | 1.84 | |
| 15 Feb 2022 | 5.61% | 2.68 | |
| 28 Feb 2022 | 5.45% | 2.90 | 10-K filed, results (8-K) |
| 15 Mar 2022 | 5.99% | 3.61 | |
| 31 Mar 2022 | 6.36% | 4.32 | |
| 14 Apr 2022 | 6.26% | 4.96 | |
| 29 Apr 2022 | 7.87% | 3.73 | |
| 13 May 2022 | 8.36% | 4.58 | 10-Q filed, results (8-K) |
| 31 May 2022 | 7.53% | 8.03 | |
| 15 Jun 2022 | 8.17% | 2.14 | |
| 30 Jun 2022 | 5.95% | 1.68 | |
| 15 Jul 2022 | 5.25% | 2.13 | |
| 29 Jul 2022 | 4.80% | 4.58 | |
| 15 Aug 2022 | 5.00% | 3.62 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 4.63% | 5.86 | |
| 15 Sep 2022 | 5.09% | 1.52 | |
| 30 Sep 2022 | 4.16% | 2.27 | |
| 14 Oct 2022 | 3.75% | 5.20 | |
| 31 Oct 2022 | 2.91% | 5.87 | |
| 15 Nov 2022 | 2.69% | 4.05 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 2.65% | 5.08 | |
| 15 Dec 2022 | 2.56% | 6.83 | |
| 30 Dec 2022 | 2.44% | 4.28 |
See also: Cardiff Oncology, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.